CRY1 and B-cell chronic lymphocytic leukemia: Of note, Hanoun et al. [10] reported that the methylation status of the CRY-1 promoter revealed a considerable prognostic influence in CLL, whereby patients with hypermethylated CRY-1 promoters showed significantly longer treatment-free survivals compared with their hypomethylated counterparts.